Results 1 - 10 of 1122

< 1 2 3 ... 112 113 >

• Synthesis and screening for acetylcholinesterase inhibitor activity of some novel 2-butyl-1,3-diaza-spiro[4,4]non-1-en-4-ones: derivatives of irbesartan key intermediate.

  [DOI: 10.1016/j.bmc.2007.07.014]
  
• Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.

  [DOI: 10.1021/jm0204237]
  
• Brabant SM; Eyraud D; Bertrand M; Coriat P. Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists., Anesthesia and analgesia

  [PubMed: 10512259]
  
• McNamee JJ; Trainor D; Michalek P. Terlipressin for refractory hypotension following angiotensin-II receptor antagonist overdose., Anaesthesia

  [PubMed: 16548975]
  [DOI: 10.1111/j.1365-2044.2006.04599]
  
• Muankaew C; Jansook P; Loftsson T. Evaluation of ?-cyclodextrin effect on permeation of lipophilic drugs: application of cellophane/fused octanol membrane., Pharmaceutical development and technology

  [PubMed: 27146583]
  [DOI: 10.1080/10837450.2016.1180394]
  
• Satoh M; Haga T; Hosaka M; Imai Y; Obara T; Metoki H; Murakami T; Kikuya M; Inoue R; Asayama K; Mano N; Ohkubo T. The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements., Journal of hypertension

  [PubMed: 27027425]
  [DOI: 10.1097/HJH.0000000000000902]
  
• Jenkins TL; Coleman AE; Schmiedt CW; Brown SA. Attenuation of the pressor response to exogenous angiotensin by angiotensin receptor blockers and benazepril hydrochloride in clinically normal cats., American journal of veterinary research

  [PubMed: 26309109]
  [DOI: 10.2460/ajvr.76.9.807]
  
• Rizos CV; Liberopoulos EN; Tellis K; DiNicolantonio JJ; Tselepis AD; Elisaf MS. Combining rosuvastatin with angiotensin-receptor blockers of different PPAR?-activating capacity: effects on high-density lipoprotein subfractions and associated enzymes., Angiology

  [PubMed: 24288364]
  [DOI: 10.1177/0003319713512556]
  
• Kikuchi K; Tancharoen S; Ito T; Morimoto-Yamashita Y; Miura N; Kawahara K; Maruyama I; Murai Y; Tanaka E. Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke., International journal of molecular sciences

  [PubMed: 24065095]
  [DOI: 10.3390/ijms140918899]
  
• Antoniou T; Camacho X; Yao Z; Gomes T; Juurlink DN; Mamdani MM. Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study., CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

  [PubMed: 23836857]
  [DOI: 10.1503/cmaj.121771]